ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Wegener’s granulomatosis"

  • Abstract Number: 095 • 2020 Pediatric Rheumatology Symposium

    Pyoderma Gangrenosum Ulceration as a Presenting Feature of Pediatric Granulomatosis with Polyangiitis (GPA)

    Rotem Semo1, Rotem Tal 2, Tomas Dallos 3, Liora Harel 4, Lukas Plank 3 and Linda Wagner-Weiner 1, 1university of chicago, chicago, Illinois, 2schneider medical center, Ramat Gan, Israel, 3National Institute of Child Diseases, Bratislava, Slovakia, 4Schneider Hospital, Tel Aviv University, Petah-Tiqva, Israel

    Background/Purpose:  GPA is a form of anti-neutrophilic cytoplasmic antibody vasculitis affecting small to medium sized vessels and involves most commonly the kidneys and the respiratory…
  • Abstract Number: 872 • 2019 ACR/ARP Annual Meeting

    Granulomatosis with Polyangiitis Sustained Remission Off-Therapy: Data from the French Vasculitis Study Group Registry

    Xavier Puéchal for the French Vasculitis Study Group1, Michele Iudici 2, Christian Pagnoux 3, Alexandre Karras 4, Pascal Cohen 1, François Maurier 5, Thomas Quémeneur 6, François Lifermann 7, Mohamed Hamidou 8, Luc Mouthon 1, Benjamin Terrier 1 and Loic Guillevin 1, 1National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin, Paris, France, 2National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin and Geneva Switzerland, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin and Toronto Canada, Paris, France, 4Paris HEGP, Paris, France, 5Service de Médecine Interne, Hôpital Belle Isle, Metz, Metz, France, 6CH Valenciennes, Valenciennes, France, 7CH Dax, Dax, France, 8CHU Nantes, Nantes, France

    Background/Purpose: Data on granulomatosis with polyangiitis (GPA) sustained remission off-therapy (SROT) are limited and it is unknown whether disease characteristics or treatment regimen may affect…
  • Abstract Number: 1677 • 2019 ACR/ARP Annual Meeting

    Management of Severe Renal Disease in Anti-Neutrophil-Cytoplasmic-Antibodies Associated Vasculitis: Role of Rituximab and Plasma Exchange?

    Pauline Morel 1, Alexandre Karras 2, Raphael Porcher 3, Xavier Belenfant 4, Vincent Audard 5, Cédric Rafat 6, Guillaume Hanouna 7, Séverine Beaudreuil 8, Cédric Vilain 9, Aurélie Hummel 10, Benjamin Terrier 11, Evangeline Pillebout 12, Matthieu Groh 13, Romain Jouenne 14, Robin Dhote 15, Olivier Fain 16, Matthieu Ponsoye 17, Nicolas Noel 18, Nicolas Limal 19, Loïc Guillevin 11, Luc Mouthon 11 and Alexis Régent11, 1Cochin Hospital, Paris, France, 2Paris HEGP, Paris, France, 3Hotel Dieu Hospital, Paris, France, 4Service de néphrologie, Hôpital André Grégoire, 56 Boulevard de la Boissière Montreuil, France, Montreuil, Ile-de-France, France, 5Henri Mondor Hospital, Créteil, France, 6Tenon Hospital, Paris, France, 7Service de néphrologie, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri Huchard, Paris, France., Paris, Ile-de-France, France, 8Bicetre Hospital, Le Kremlin Bicetre, France, 9Service de néphrologie hémodialyse, Hôpital Ambroise Paré, APHP, 9 avenue Charles de Gaulle, Boulogne-Billancourt, France, Boulogne-Billancourt, Ile-de-France, France, 10APHP, Paris, France, 11National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin, Paris, France, 12Service de néphrologie et transplantation, Hôpital Saint-Louis, AP-HP, 1 avenue Claude Vellefaux, Paris, France., Paris, Ile-de-France, France, 13Service de médecine interne, maladies systémiques, Hôpital Saint Louis, AP-HP, 1 avenue Claude Vellefaux, Paris, France, Paris, Ile-de-France, France, 14Service de médecine interne, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri Huchard, Paris, France, Paris, Ile-de-France, France, 15Service de médecine interne, Hôpital Avicenne, AP-PH, 125 rue de Stalingrad, Bobigny, France, Bobigny, Ile-de-France, France, 16Service de médecine interne, Hôpital Saint-Antoine, AP-HP, 184 rue du Faubourg Saint-Antoine, Paris, France, Paris, Ile-de-France, France, 17Service de médecine interne, Hopital Ambroise Paré, Boulogne-Billancourt, Boulogne-Billancourt, Ile-de-France, France, 18Service de médecine interne et immunologie clinique, Hôpital Bicêtre, AP-HP, 78 rue du Général Leclerc, Kremlin-Bicêtre, France, Kremil-Bicêtre, Ile-de-France, France, 19Service de médecine interne, Hôpital Henri-Mondor, AP-HP, 51 Avenue du Maréchal de Lattre de Tassigny, Créteil, France, Créteil, Ile-de-France, France

    Background/Purpose: Induction therapy for severe ANCA-associated vasculitides (AAVs) is based on the combination of glucocorticoids and cyclophosphamide (CYC) or rituximab (RTX). For patients with severe…
  • Abstract Number: 1682 • 2019 ACR/ARP Annual Meeting

    Inpatient Epidemiology of Granulomatosis with Polyangiitis in the United States

    Patompong Ungprasert1, Matthew Koster 2, Wisit Cheungpasitporn 3, Karn Wijarnpreecha 4, Charat Thongprayoon 2 and Paul Kroner 5, 1Cleveland Clinic, Cleveland, OH, Bangkok, Thailand, 2Mayo Clinic Rochester, Rochester, MN, 3University of Mississippi Medical Center, Jackson, MS, 4Mayo Clinic Florida, Jacksonville, FL, 5Mayo Clinic Florida, Jacksonville

    Background/Purpose: Granulomatosis with polyangiitis (GPA, formerly known and Wegener’s granulomatosis) is a major subtype of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis characterized by granulomatous inflammation of…
  • Abstract Number: 2626 • 2019 ACR/ARP Annual Meeting

    Cell-free Mitochondrial DNA Levels in Granulomatosis with Polyangiitis

    Lindsay Lally1, Sebastian E. Sattui 2, Jackie Finik 3, Augustine Choi 4, Rennie Rhee 5, Peter Merkel 6, W. Joseph McCune 7, E William St. Clair 8, Ulrich Specks 9, John Stone 10 and Robert Spiera 1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery, New York, NY, New York, NY, 4Weill Cornell Medicine, New York, 5University of Pennsylvania, Division of Rheumatology, Philadelphia, PA, 6University of Pennsylvania, Philadelphia, PA, 7University of Michigan, Ann Arbor, MI, 8Duke, Raleigh, 9Mayo Clinic College of Medicine, Rochester, MN, 10Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA

    Background/Purpose: Circulating cell-free mitochondrial DNA (mtDNA) is released during non-apoptotic processes such as NETosis. Increased levels of mtDNA are associated with autophagic dysfunction and inflammasome…
  • Abstract Number: 2788 • 2019 ACR/ARP Annual Meeting

    Longitudinal Changes in the Nasal Microbiome and Disease Activity in Patients with Granulomatosis with Polyangiitis

    Rennie Rhee1, Antoine Sreih 2, Jung-Jin Lee 3, Kyle Bittinger 3, Lisa Mattei 3, Ronald Collman 4 and Peter Merkel 2, 1University of Pennsylvania, Division of Rheumatology, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania, Philadelphia

    Background/Purpose: Microbial organisms have been theorized to contribute to disease activity in granulomatosis with polyangiitis (GPA) but little is known about what changes occur in…
  • Abstract Number: 2789 • 2019 ACR/ARP Annual Meeting

    Neutrophil Extracellular Traps Induce Tissue-Invasive Macrophages in Granulomatosis with Polyangiitis Dominated by Ear, Nose and Throat Manifestations

    Mitsuhiro Akiyama1, Nour Ibrahim 2, Markus Zeisbrich 1, Peter Hwang 1, Jorg Goronzy 1 and Cornelia Weyand 1, 1Stanford University, Stanford, CA, 2Stanford University, Stanford University

    Background/Purpose: Granulomatosis with polyangiitis (GPA) is a small vessel vasculitis characterized by acute and chronic tissue destruction in the nose, sinuses, lungs and kidneys. In…
  • Abstract Number: L04 • 2018 ACR/ARHP Annual Meeting

    Pediatric Open-Label Clinical Study of Rituximab for the Treatment of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

    Paul Brogan1, Gavin Cleary2, Aimee O. Hersh3, Ozgur Kasapcopur4, Satyapal Rangaraj5, Rae S.M. Yeung6, Andrew Zeft7, Simone Melega8, Paul Brunetta9, Jennifer Cooper10, Pooneh Pordeli11 and Patricia B. Lehane12, 1Infection Inflammation and Rheumatology, UCL GOL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 2Alder Hey Children's Hospital, Liverpool, United Kingdom, 3Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 4Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey, 5Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom, 6Paediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 7Center for Pediatric Rheumatology & Immunology, The Cleveland Clinic Foundation, Cleveland, OH, 8F. Hoffmann-La Roche, Basel, Switzerland, 9Genentech, Inc., South San Francisco, CA, 10Pediatric Rheumatology, Univ. of California San Francisco, San Francisco, CA, 11Hoffmann-La Roche Ltd., Mississauga, ON, Canada, 12Roche Products Ltd., Welwyn Garden City, United Kingdom

    Background/Purpose: PePRS is a Phase IIa international, multicenter, open-label single arm study of rituximab in pediatric patients with newly diagnosed or relapsing GPA or MPA.…
  • Abstract Number: 2728 • 2018 ACR/ARHP Annual Meeting

    Validation of the Draft Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Indian Patients with ANCA Associated Vasculitis

    Aman Sharma1, Adarsh MB2, GSRSNK Naidu3, Manish Rathi4, Kusum Sharma5, Varun Dhir6, Ritambhra Nada7, Ranjana Minz8 and Sanjay Jain9, 1Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 2Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 3PGIMER, cHANDIGARH, India, 4Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 5Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 6Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 7Postgraduate Institute of Medical Education and Research, Chandigarh, India, 8Department of Immunopathology,, PGIMER,, Chandigarh, India, 9Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India

    Background/Purpose: A draft classification criteria of GPA was proposed at ACR meeting in San Diego in 2017. The present criteria is a modification of ACR/EULAR…
  • Abstract Number: 2729 • 2018 ACR/ARHP Annual Meeting

    Increased Risk of Cerebrovascular Accident Among Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review and Meta-Analysis of Cohort Studies

    Patompong Ungprasert1, Karn Wijarnpreecha2 and Wisit Cheungpasitporn3, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, University of Mississippi Medical center, Jackson, MS

    Increased Risk of Cerebrovascular Accident among Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review and Meta-analysis of Cohort StudiesAbstractBackground/Purpose: An increased risk of cardiovascular…
  • Abstract Number: 2737 • 2018 ACR/ARHP Annual Meeting

    Opportunistic Infections in Medium and Small-Sized Vessel Vasculitis: Based on a Retrospectivestudy on 108 Patients

    Raphaele Mestiri1, Lafarge Antoine2, Jean-Jacques Tudesq3, Marc Pineton de Chambrun4, Melanie Roriz5, Stéphane Bally6, Laurent Alric7, Damien Sène8, Thomas Quémeneur9, Cécile-Audrey Durel10, Brigitte Gilson11, Alice Berezne12, Anne-Marie Ruppert13, Raphaele Seror14, Philippe Guilpain15, Xavier Puéchal16, Luc Mouthon17, Loïc Guillevin16 and Benjamin Terrier18, 1Internal Medicine, Cochin hospital, Paris, France, 2Medecine Interne, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, 3Internal Medicine, CHU Montpellier, Montpellier, France, 4Université Pierre et Marie Curie, Paris, France, 5Université Paris-Diderot, Paris, France, 6Nephrology, CH Chambery, Chambery, France, 7Internal Medicine, CHU Toulouse, Toulouse, France, 8Lariboisière Hospital, Paris Diderot University, Paris, France, 9Department of Internal Medicine, CH of Valenciennes, France, Valenciennes, France, 10Internal Medicine, Hôpital Edouard Herriot, lyon, France, 11Internal Medicine, CH Verdun, Verdun, France, 12Internal Medicine, CH Annecy, Annecy, France, 13Pulmonology, Tenon hospital, Paris, France, 14Hopitaux Universitaires Paris Sud, Kremlin Bicetre, France, Rheumatology, Université Paris Sud, Le Kremlin Bicetre, France, 15Montpellier, Montpellier, France, 16Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 17Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, 18Centre de Référence des Maladies Auto-immunes et Systémiques Rares, Vascularites Nécrosantes et Sclérodermie Systémique, Service de Médecine Interne, Hôpital Cochin, APHP, INSERM U1016, Université Paris Descartes, Paris, France

    Background/Purpose: Overall survival has been markedly improved during the last decades in systemic vasculitis. In contrast, the use of immunosuppressive agents led to an increased…
  • Abstract Number: 1769 • 2018 ACR/ARHP Annual Meeting

    Efficacy and Safety of Biomimic Rituximab in Granulomatosis with Polyangiitis – Experience from a Single Tertiary Care Centre in India

    Aman Sharma1, Sakshi Mittal2, GSRSNK Naidu3, Saket Jha2, Manish Rathi4, Vikas Sharma2, Arghya Chattopadhyay5, Varun Dhir6, Kusum Sharma7, Ranjana Minz8, Ritambhra Nada9 and Sanjay Jain10, 1Clinical Immunology and Rheumatology Services, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 2Internal Medicine, PGIMER, Chandigarh, India, 3PGIMER, cHANDIGARH, India, 4Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 5PGIMER, Chandigarh, India, 6Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, Chandigarh, India, 7Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 8Department of Immunopathology,, PGIMER,, Chandigarh, India, 9Postgraduate Institute of Medical Education and Research, Chandigarh, India, 10Postgraduate Institute of Medical Education and Research, Chandigarh, India, CHANDIGARH, India

    Background/Purpose: Though rituximab(RTX) has become a standard of care for remission induction and maintenance in Granulomatosis with Polyangiitis(GPA), there is very limited data on the…
  • Abstract Number: 2720 • 2018 ACR/ARHP Annual Meeting

    30-Day Hospital Readmission for Granulomatosis with Polyangiitis: Analysis from National Readmission Database

    Yiming Luo1, Changchuan Jiang1, Ana Belen Arevalo Molina1, Shane Murray1, Maria Salgado2 and Jiehui Xu3, 1Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY, 3Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY

    Background/Purpose: Granulomatosis with polyangiitis (GPA) is a systemic vasculitis with multi-organ involvement which can lead to frequent hospitalizations. Our study is to investigate characteristics and…
  • Abstract Number: 893 • 2017 ACR/ARHP Annual Meeting

    Efficacy and Safety of Belimumab in Combination with Azathioprine for Remission Maintenance in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: A Multicenter Randomized, Placebo-Controlled Study

    David Jayne1, Daniel Blockmans2, Raashid Luqmani3, Beulah Ji4, Yulia Green5, Leanne Hall6, David Roth7 and Peter A. Merkel8, 1Vasculitis and Lupus Clinic, Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 2General Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium, 3Botnar Research Centre, University of Oxford, Oxford, United Kingdom, 4GSK Stockley Park, Uxbridge, United Kingdom, 5GSK Stockley Park, Stockley Park, United Kingdom, 6GSK Stevenage, Stevenage, United Kingdom, 7GSK Collegeville, Collegeville, PA, 8Division of Rheumatology, University of Pennsylvania, Philadelphia, MN

    Background/Purpose: GPA (Wegener’s) and MPA are organ- and life-threatening systemic vasculitides characterized by the presence of ANCA-associated vasculitis (AAV), implicating B cells in disease pathogenesis.…
  • Abstract Number: 1010 • 2017 ACR/ARHP Annual Meeting

    Identification of Circulating Biomarkers of Disease Activity and Organ Involvement in ANCA-Associated Vasculitis By Targeted Proteomics

    Jun Ishizaki1, Ayako Takemori2, Koichiro Suemori1, Takuya Matsumoto1, Yoko Akita1, Masaki Yasukawa1, Nobuaki Takemori2 and Hitoshi Hasegawa1, 1Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan, 2Division of Proteomics Research, Proteo-Science Center, Ehime University, Ehime, Japan

    Background/Purpose: Targeted proteomics, which involves quantitative analysis of targeted proteins using selected reaction monitoring (SRM) mass spectrometry, has emerged as a new methodology for discovery…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology